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Abstract
Background

Reactive oxygen species (ROS) contribute to myocardial protection during ischemic preconditioning, but the role
of the ROS in protection against ischemic injury produced by volatile anesthetics has only recently been
explored. We tested the hypothesis that ROS mediate isoflurane-induced preconditioning in vivo.

Methods

Pentobarbital-anesthetized rabbits were instrumented for measurement of hemodynamics and were subjected
to a 30 min coronary artery occlusion followed by 3 h reperfusion. Rabbits were randomly assigned to receive
vehicle (0.9% saline), or the ROS scavengers N-acetylcysteine (NAC; 150 mg/kg) or N-2-mercaptopropionyl
glycine (2-MPG; 1 mg. kg(-1).min(-1)), in the presence or absence of 1.0 minimum alveolar concentration (MAC)
isoflurane. Isoflurane was administered for 30 min and then discontinued 15 min before coronary artery
occlusion. A fluorescent probe for superoxide anion production (dihydroethidium, 2 mg) was administered in the
absence of the volatile anesthetic or 5 min before exposure to isoflurane in 2 additional groups (n = 8).
Myocardial infarct size and superoxide anion production were assessed using triphenyltetrazolium staining and
confocal fluorescence microscopy, respectively.

Results

Isoflurane (P < 0.05) decreased infarct size to 24 +/- 4% (mean +/- SEM; n = 10) of the left ventricular area at risk
compared with control experiments (43 +/- 3%; n = 8). NAC (43 +/- 3%; n = 7) and 2-MPG (42 +/- 5%; n = 8)
abolished this beneficial effect, but had no effect on myocardial infarct size (47 +/- 3%; n = 8 and 46 +/- 3; n = 7,
respectively) when administered alone. Isoflurane increased superoxide anion production as compared with
control experiments (28 +/- 12 -6 +/- 9 fluorescence units; P < 0.05).

Conclusions

The results indicate that ROS produced following administration of isoflurane contribute to protection against
myocardial infarction in vivo.

Topics:
isoflurane, oryctolagus cuniculus, reactive oxygen species, myocardial infarction

Large quantities of reactive oxygen species (ROS) released during reperfusion after coronary artery occlusion
damage proteins responsible for intracellular homeostasis, produce tissue injury, 1–3depress contractile
function, and increase myocardial infarct size. In contrast, small quantities of ROS may exert beneficial effects
during ischemia and reperfusion when released before a prolonged ischemic event. 4ROS derived from
mitochondria during a brief ischemic episode produce preconditioning. 5,6Free radical scavengers administered
during ischemic preconditioning (IPC) markedly attenuate the protective effect of the preconditioning stimulus
on infarct size. 5,7These data suggest that IPC is mediated in part by small quantities of ROS released during
preconditioning. Volatile anesthetics protect myocardium against infarction through a signal transduction
pathway that includes adenosine type 1 receptors, 8–10protein kinase C, 9,11inhibitory guanine regulatory
proteins, 12and mitochondrial and sarcolemmal adenosine triphosphate-regulated potassium (KATP)
channels. 13–16A recent investigation by Müllenheim et al . provides compelling evidence that ROS also
mediate myocardial protection produced by volatile anesthetics. 17We sought to confirm and extend these
important results by examining the hypothesis that ROS scavengers inhibit isoflurane-induced protection against
irreversible ischemic injury. We further tested the hypothesis that isoflurane directly generates ROS in rabbit
ventricular myocardium in vivo using a confocal microscopic technique combined with the superoxide anionspecific fluorescent probe dihydroethidium.

Methods
All experimental procedures and protocols used in this investigation were reviewed and approved by the Animal
Care and Use Committee of the Medical College of Wisconsin. Furthermore, all conformed to the Guiding
Principles in the Care and Use of Animals of the American Physiologic Society and were in accordance with
the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, D.C., 1996).

General Preparation

Male New Zealand White rabbits weighing between 2.5 and 3.0 kg were anesthetized with intravenous sodium
pentobarbital (30 mg/kg). Additional doses of pentobarbital were titrated as required to assure that pedal and
palpebral reflexes were absent throughout the experiment. A tracheostomy was performed through a ventral
midline incision, and the trachea was cannulated. The rabbits were ventilated (model 683, Harvard, Holliston,
MA) with positive pressure using a room air-oxygen mixture (Fio2= 0.33). Arterial blood gas tensions and acidbase status were maintained within a normal physiologic range (pH 7.35–7.45, Paco225–40 mmHg, and Pao290–
150 mmHg) by adjusting the respiratory rate or tidal volume throughout the experiment. Body temperature was
maintained with a heating blanket. Heparin-filled catheters were inserted into the right carotid artery and the
left jugular vein for measurement of arterial blood pressure and fluid or drug administration, respectively.
Maintenance fluids consisted of 0.9% saline (15 ml · kg−1· h−1) that were continued for the duration of the
experiment. A left thoracotomy was performed at the fourth intercostal space, and the heart was suspended in
a pericardial cradle. A heparin-filled catheter was inserted into the left atria for the subsequent administration
of dihydroethidium used to detect ROS production. A prominent branch of the left anterior descending coronary
artery (LAD) was selected, and a silk ligature was placed around this artery approximately halfway between the

base and apex for the production of coronary artery occlusion and reperfusion. Each rabbit was anticoagulated
with 500 U of heparin immediately before LAD occlusion. Coronary artery occlusion was verified by the presence
of epicardial cyanosis and regional dyskinesia in the ischemic zone, and reperfusion was confirmed by observing
an epicardial hyperemic response. Hemodynamics were continuously recorded on a polygraph (Grass model 7)
throughout experimentation.

Experimental Protocol

The experimental design used in the present investigation is illustrated in figure 1. Thirty minutes after
instrumentation was completed and calibrated, baseline systemic hemodynamics were recorded. Rabbits were
randomly assigned to one of six experimental groups using a Latin square design. All rabbits underwent a 30 min
LAD occlusion followed by 3 h reperfusion. Rabbits received intravenous vehicle (0.9% saline), N-acetylcysteine
(NAC; 150 mg/kg over 30 min), 18or N-2-mercaptopropionyl glycine (2-MPG; 1 mg · kg−1· min−1over 75 min) 5in
the presence or absence of 1.0 minimum alveolar concentration (MAC) isoflurane. The end-tidal MAC value used
for rabbits in the present investigation was 2.1%. 19End-tidal concentrations of isoflurane were measured at the
tip of the tracheostomy tube with an infrared anesthetic analyzer that was calibrated with known standards
before and during experimentation.

Fig. 1. Schematic illustration of the experimental protocol. ISO = isoflurane; 2-MPG =N -2-mercaptopropionyl
glycine; NAC = N-acetylcysteine.

Determination of Myocardial Infarct Size

Myocardial infarct size was measured as previously described. 20Briefly, the left ventricular (LV) area at risk for
infarction (AAR) was separated from surrounding normal areas, and the two regions were incubated at 37°C for
20 to 30 min in 1% 2,3,5-triphenyltetrazolium chloride in 0.1 m phosphate buffer adjusted to pH 7.4. After
overnight storage in 10% formaldehyde, infarcted and noninfarcted myocardium within the AAR were carefully
separated and weighed. Infarct size was expressed as a percentage of the AAR. Rabbits that developed
intractable ventricular fibrillation and those with an AAR less than 15% of LV mass were excluded from
subsequent analysis.

ROS Detection

Dihydroethidium is oxidized by intracellular ROS to produce fluorescent ethidium that subsequently binds to
DNA (Eth-DNA) further amplifying its fluorescence. 21The fluorescence observed after activation of the Eth-DNA
complex is generally stable, but may be reduced by the presence of hydroxyl radicals. 22,23Thus, an increase in
dihydroethidium oxidation to Eth-DNA and the subsequent increase in fluorescence are highly suggestive of
superoxide anion generation. In two additional groups of rabbits (n = 8), dihydroethidium (2 mg) was rapidly
injected into the left atrium 5 min before the administration of isoflurane (1 MAC) or at the corresponding time
point in rabbits that were not subsequently exposed to the volatile anesthetic. Isoflurane was discontinued after
30 min, and the rabbits were euthanized after 1 h with a lethal dose of pentobarbital. The heart was rapidly

excised. The LV was isolated, divided into four sections of equal size, and frozen in liquid nitrogen. Kryostat
sections (20 μm) of the LV were mounted on standard microscope slides. Using a laser fluorescence imaging
system (MRC 600 Laser Scanning Confocal Microscopic Imaging System; Bio-Rad Laboratories; Philadelphia, PA)
mounted on a Microscope (Optiphot; Nikon Corporation; Tokyo, Japan) images were recorded and stored for
subsequent offline analysis on a computer workstation equipped with image analysis software (MetaMorph;
Universal Imaging Corporation; Downingtown, PA). Use of the 40× objective yielded a 400× end magnification on
a 292 × 195 μm 2digital image (768 × 512 pixels). The signal-to-noise ratio was enhanced using the Kalman
method. Excitation was produced using a Krypton-Argon laser at a wavelength of 488 nm, and emitted
fluorescence measured at 550 nm after long pass filtering. The pixel intensity of each myocyte nucleus was
determined. Background was identified as an area without cells or with minimal cytosol fluorescence. In each
rabbit, 20 Kalman-averaged images were obtained and approximately 6 to 8 dihydroethidium-stained
myocardial cells were analyzed by subtraction of background fluorescence from the pixel intensity of the
myocardial nuclei.

Statistical Analysis

Statistical analysis of data within and between groups was performed with analysis of variance (ANOVA) for
repeated measures followed by Student Newman–Keuls test. Changes within and between groups were
considered statistically significant when the P value was less than 0.05. Student t test was used to compare
differences of pixel intensities in ROS detection experiments. Statistical significance was defined as P < 0.05. All
data are expressed as mean ± SEM.

Results
Sixty-one rabbits were instrumented to obtain 48 successful myocardial infarct size experiments. Eight rabbits
were excluded because the AAR/LV did not exceed 15% (1 control; 2 isoflurane alone; 1 isoflurane + 2-MPG; 3
isoflurane + NAC; and 1 NAC alone). Five rabbits were excluded because of intractable ventricular fibrillation (1
control; 2 isoflurane alone; 1 isoflurane + 2-MPG; and 1 2-MPG alone).

Systemic Hemodynamics

No differences in hemodynamics were observed between experimental groups under control conditions (table
1). Isoflurane significantly (P < 0.05) decreased mean arterial pressure and rate-pressure product in the presence
or absence of ROS scavengers. Hemodynamics returned to baseline values 15 min after isoflurane had been
discontinued. Coronary artery occlusion and reperfusion produced similar decreases in mean arterial pressure
and rate-pressure product in each experimental group.

Table 1 . Systemic Hemodynamics
Reperfusion (h)
1
2

Baseline
Isoflurane
Preocclusion 30 min CAO
3
HR (min-1)
CON
259 ± 11
266 ± 11
264 ± 11
260 ± 10
265 ± 10
268 ± 12
ISO
260 ± 10
273 ± 8
260 ± 5
240 ± 9*
242 ± 9*
235 ± 10*
238 ± 9*
ISO+2-MPG
255 ± 9
282 ± 6*
269 ± 7 275 ± 13*
249 ± 8
241 ± 6
242 ± 2
ISO+ NAC
251 ± 7
276 ± 7*
275 ± 6*
270 ± 8
265 ± 8
264 ± 4
270 ± 7
2-MPG
243 ± 9
259 ± 8
263 ± 13
234 ± 5
230 ± 9
236 ± 12
NAC
255 ± 9
261 ± 7
255 ± 11
248 ± 11
251 ± 13
247 ± 13
MAP (mmHg)
CON
88 ± 4
85 ± 3
75 ± 2*
83 ± 4
81 ± 6
78 ± 5*
ISO
89 ± 3
67 ± 5*
82 ± 3
73 ± 4*
74 ± 5*
77 ± 4*
79 ± 4*
ISO + 2-MPG
89 ± 2
51 ± 5*
79 ± 4
68 ± 6*
75 ± 6
76 ± 5
74 ± 4
ISO + NAC
90 ± 4
62 ± 2*
82 ± 4
77 ± 4*
82 ± 5
83 ± 5
83 ± 3
2-MPG
90 ± 3
85 ± 2
69 ± 6*
72 ± 6*
74 ± 7*
74 ± 7*
NAC
87 ± 3
86 ± 2
75 ± 4*
75 ± 2*
75 ± 3*
76 ± 3*
-3
RPP (bpm · mmHg · 10 )
CON
26.3 ± 1.9
26.6 ± 1.6 23.0 ± 1.5*
25.0 ± 2.1
24.7 ± 2.3 23.6 ± 2.3*
ISO
26.3 ± 1.5 22.8 ± 1.4*
25.3 ± 1.0 20.5 ± 1.3*
20.9 ± 1.8* 20.8 ± 1.4* 21.5 ± 1.6*
ISO + 2-MPG
25.7 ± 1.0 20.4 ± 1.7*
25.6 ± 1.0 22.0 ± 1.6*
21.8 ± 1.9* 20.7 ± 1.6* 20.2 ± 0.9*
ISO + NAC
26.0 ± 1.4
23.2 ± 1.1
27.0 ± 1.3
24.3 ± 1.6
24.8 ± 1.4
24.9 ± 1.4
25.5 ± 0.7
2-MPG
24.4 ± 0.9
25.3 ± 1.1 20.5 ± 1.6*
18.9 ± 1.2* 19.2 ± 1.8* 19.8 ± 1.7*
NAC
25.0 ± 1.6
25.3 ± 1.1 21.8 ± 1.4*
21.2 ± 1.4* 21.8 ± 1.9* 21.7 ± 1.9*
Data are mean ± SEM.
* Significantly (P < 0.05) different from baseline.
CAO = coronary artery occlusion; HR = heart rate; MAP = mean arterial blood pressure; RPP = rate-pressure product; CON = control; ISO = isoflurane; 2MPG = N-2-mercaptopropionyl glycine; NAC = N-acetylcysteine.

Myocardial Infarct Size

The body weight, LV weight, AAR weight, and AAR/LV were similar between groups (table 2). Isoflurane reduced
myocardial infarct size (24 ± 4% of the AAR; n = 10;fig. 2) as compared to control experiments (43 ± 3%; n = 8).
NAC and 2-MPG alone did not affect infarct size (47 ± 3%; n = 8 and 46 ± 3%; n = 7, respectively), but these ROS
scavengers blocked the protective effects of isoflurane (43 ± 3%; n = 7 and 42 ± 5%; n = 8, respectively).
Table 2 . Area at Risk
Body Weight (g)

LV WT (g)
3.16 ± 0.11
3.16 ± 0.10
3.10 ± 0.13
2.99 ± 0.11
3.10 ± 0.08
2.88 ± 0.08

AAR WT (g)
0.94 ± 0.13
1.04 ± 0.09
1.04 ± 0.13
0.88 ± 0.10
1.08 ± 0.12
0.83 ± 0.07

AAR/LV (%)

CON
2960 ± 50
30 ± 4
ISO
3050 ± 80
33 ± 3
ISO + 2-MPG 3000 ± 70
33 ± 4
ISO + NAC
2780 ± 50
29 ± 3
2-MPG
2900 ± 40
34 ± 3
NAC
2790 ± 80
29 ± 3
Data are mean ± SEM.
LV = left ventricle; WT = weight; AAR = area at risk; CON = control; ISO = isoflurane; 2-MPG = N-2mercaptopropionyl glycine; NAC = N-acetylcysteine.

Fig. 2. Myocardial infarct size expressed as a percentage of the left ventricular area at risk (AAR) in rabbits
receiving saline (CON), N-2-mercaptopropionyl glycine (2-MPG), or N-acetylcysteine (NAC) in the presence and
absence of 1.0 MAC isoflurane (ISO). *Significantly (P < 0.05) different from ISO.

Reactive Oxygen Species Production

Ethidium-DNA fluorescence was detected in all images examined (fig. 3). Rabbits pretreated with 1.0 MAC
isoflurane demonstrated enhanced fluorescence in myocardial nuclei compared with the cytosol, in contrast to
the findings in rabbits that did not receive the volatile agent (fig. 4). Fluorescence intensity in myocardial nuclei
was significantly greater (28 ± 12 vs. −6 ± 9 fluorescence units) in isoflurane-pretreated compared with
untreated rabbits.

Fig. 3. Representative photomicrographs demonstrating enhanced production of superoxide anion by the
expression of fluorescent ethidium bound to nuclear DNA. The fluorescence in myocardial nuclei in rabbits
treated with 1.0 MAC isoflurane for 30 min (B ) was more intense than that observed in rabbits that were not
exposed to isoflurane (A ).

Fig. 4. Histogram depicting the effects of isoflurane on superoxide anion production measured using
dihydroethidium staining. Fluorescence of ethidium bound to nuclear DNA was significantly (*P < 0.05)
increased by administration of isoflurane.

Discussion
Mitochondria have been shown to produce small quantities of ROS during brief periods of ischemia that cause
preconditioning. 5,6The protective effects of the selective mitochondrial KATPchannel opener, diazoxide, were
blocked by pretreatment with ROS scavengers in isolated rabbit hearts. 24Diazoxide also increased oxidation of
the ROS probe mitotracker orange in vitro , an action that was attenuated by pretreatment with the selective
mitochondrial KATPchannel antagonist 5-hydroxydecanoate (5-HD) or the ROS scavengers NAC and 2MPG. 25Diazoxide directly increased ROS production as measured by the hydrogen peroxide probe 2’,7’dichlorofluorescein diacetate 26in rat ventricular myocytes and isolated hearts. Whether volatile anesthetics
increase ROS production or modulate the actions of oxygen-derived free radicals as potential mechanisms by
which these agents produce myocardial protection remains unclear. Sevoflurane has been shown to impair
endothelium-dependent relaxation of canine mesenteric arteries by an oxygen-derived free radical
mechanism. 27Isoflurane reduced hydroxyl radical production in the ischemic rat heart. 28In contrast,
Müllenheim et al. 17very recently demonstrated that 2-MPG and another ROS scavenger Mn(III)tetrakis(4benzoic acid)porphyrine chloride abolished the protective effect of isoflurane in rabbit hearts. These data were
the first to implicate a role for ROS in anesthetic-induced preconditioning, and suggested that volatile agents
may be capable of producing small quantities of ROS that serve as mediators of cardioprotection.

The results of the present investigation confirm and extend the findings of Müllenheim et al. 17and indicate
that the ROS scavengers NAC and 2-MPG blocked the reduction in myocardial infarct size produced by isoflurane
when these drugs were administered during exposure to isoflurane. The results further demonstrate that
intensity of Eth-DNA fluorescence measured with confocal microscopy is significantly increased during a 30 min
pretreatment with 1.0 MAC isoflurane. These data indicate that isoflurane directly increases superoxide anion
generation independent of coronary artery occlusion and reperfusion and strongly imply that this ROS
production mediates protection against irreversible ischemic injury. Mitochondria are a likely source for the
production of the superoxide anion. 29Superoxide anion generated experimentally from the enzyme complex
hypoxanthine–xanthine oxidase mimics the protective effects of preconditioning. 30Thus, it appears likely that
superoxide anion produced by mitochondria may activate intracellular signaling responsible for the protective
effect of isoflurane. However, we did not specifically determine the source of ROS production by isoflurane or
whether the generation of this oxygen-derived free radical species is linked to mitochondrial KATPchannel
opening in the present investigation. These objectives are important goals of future research.
The specific oxygen-derived free radicals responsible for activation of the signal transduction of preconditioning
are unknown. The Cu,Zn-superoxide dismutase (SOD) inhibitor diethyldithiocarbamic acid is a selective inhibitor
of the cytosolic conversion of superoxide anion to hydrogen peroxide and abolished protection produced by
hypoxic preconditioning in embryonic cardiac myocytes. 6These results suggested that conversion of superoxide
anion to hydrogen peroxide may be an important step for oxidant induction of hypoxic preconditioning. Nacetylcysteine is a sulfhydryl-containing glutathione precursor that exerts antioxidant effects by contributing to
glutathione synthesis, serving as a glutathione peroxidase substrate, and directly scavenging several oxygenderived free radical species primarily by the actions of reduced glutathione. 31Mitochondria contain large
quantities of SOD, and the vast majority of superoxide anion generated as a consequence of mitochondrial
electron transport is enzymatically dismutated to hydrogen peroxide and oxygen by mitochondrial Mn-SOD and
cytosolic Cu,Zn-SOD. Glutathione peroxidase contained in the cytosol subsequently catalyzes the reduction of
hydrogen peroxide to water. Reduced glutathione acts as the electron donor of glutathione peroxidase in this
reaction. Thus, NAC maintains the cytosolic concentration of reduced glutathione and facilitates metabolism of
hydrogen peroxide produced by the univalent reduction of superoxide anion. 2-MPG also acts as a sulfhydryl
donor to glutathione peroxidase, and several studies indicate that 2-MPG may be more specific for
mitochondrial activity than NAC. 32–34We did not specifically identify the particular ROS scavenged by NAC or
2-MPG that was responsible for isoflurane-induced preconditioning. However, the present results indicate that
exposure to isoflurane is accompanied by the generation of superoxide anion in ventricular myocytes, most
likely in the mitochondria, in the absence of ischemia and reperfusion. Thus, it appears likely that the superoxide
anion or another ROS generated by the superoxide anion dismutation pathway is involved in the signal
transduction of isoflurane-induced preconditioning.
The present results should be interpreted within the constraints of several potential limitations. The area of the
left ventricle at risk for infarction and coronary collateral blood flow are important determinants of the extent of
myocardial infarction. The AAR was similar between experimental groups. Minimal coronary collateral blood
flow has been previously reported in rabbits. 35Thus, it is unlikely that the present results were affected by the
size of the AAR or magnitude of coronary collateral blood flow.
Isoflurane caused similar hemodynamic effects in the presence or absence of ROS scavengers, and there were
no differences in hemodynamics between groups after discontinuation of isoflurane. Thus, the present results
occurred independent of the hemodynamic effects of isoflurane and/or the ROS scavengers. Nevertheless,
coronary venous oxygen tension and myocardial oxygen consumption were not directly quantified in the present
investigation, and differences in myocardial oxygen metabolism during the administration of isoflurane with or
without ROS scavengers cannot be completely excluded from the analysis. However, no differences in primary

hemodynamic determinants of myocardial oxygen consumption were observed, and an indirect indicator (i.e. ,
rate-pressure product) of myocardial oxygen consumption was also similar between experimental groups.
Experiments using dihydroethidium as an indicator of superoxide anion production provide primarily qualitative
results. Dihydroethidium can catalyze the dismutation of superoxide anion, thus, rates of superoxide anion
production may be underestimated using this technique. 36In addition, cytochrome c can oxidize
dihydroethidium. 36It is unlikely that cytochrome c release occurred in experiments during which
dihydroethidium was used because animals were not subjected to ischemia and reperfusion. Isoflurane is
unlikely to cause cytochrome c release because this anesthetic has previously been demonstrated to decrease
apoptosis and inhibit caspase activation in ventricular myocytes. 37
In summary, the present results provide direct evidence that isoflurane generates ROS in rabbit ventricular
myocardium in vivo using a laser fluorescence confocal microscopic imaging technique. The present findings
further indicate that scavenging of these ROS by NAC and 2-MPG abolishes myocardial protection produced by
isoflurane. These findings suggest that generation of ROS by volatile anesthetics is an essential part of the
signaling pathway of anesthetic-induced preconditioning.
The authors thank David Schwabe, B.S.E.E. for technical assistance, and Mary Lorence-Hanke, A.A. (both from
the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin) for assistance in
preparation of the manuscript.
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